Invasive Breast Cancer
📧 Sign up to get email alerts when something new happens for Invasive Breast Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-08-18FDA Approved: RALOXIFENE HYDROCHLORIDE — Original Application (Modavar Pharmaceuticals LLC)
FDA approved Modavar Pharmaceuticals' original application for raloxifene hydrochloride, enabling a generic version of the drug.
-
FDA approval · 2019-08-23FDA Approved: RALOXIFENE HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark Pharmaceuticals' supplemental application for raloxifene hydrochloride (generic). The drug is indicated for postmenopa…
-
FDA approval · 2016-10-12FDA Approved: RALOXIFENE HYDROCHLORIDE — Original Application (ScieGen Pharmaceuticals Inc)
FDA approves the original application for raloxifene hydrochloride from ScieGen Pharmaceuticals Inc, providing a generic option for postmeno…
-
FDA approval · 2014-03-04FDA Approved: RALOXIFENE HYDROCHLORIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's raloxifene hydrochloride generic as an Original Application (ANDA), enabling a generic product for postmenopausal os…